top of page

for a change of pace, inna enjoys travel, sports and art.

when not working with entrepreneurs, inna is a fellow at the university of oxford, developing novel phenotype algorithms to support businesses in delivering more cost-efficient clinical trials. prior to this, inna worked in consulting, covering health financing and market access. inna holds a phd in health economics from the university of oxford, an msc in health economics and policy from the london school of economics, and a ba(hons) in economics and law from the american university of paris.

prior to redalpine, inna co-founded mable, a genomics-powered telehealth clinic for migraine care in the u.s., backed by y combinator, illumina inc and initialized capital. having gone through the full start-up life cycle from inception, regulatory approval and launch to acquisition in 2023, Inna is now closely working with founders globally to develop g2m, reimbursement and growth strategies.

oxford fellow, healthcare expert

led healthtech startup to successful acquisition

artist

"art holds a special place among my passions - it has the power to transcend time and transform the world."

"art holds a special place among my passions - it has the power to transcend time and transform the world."

investment team

+

dr. inna thalmann

associate

artist

investment team

+

dr. inna thalmann

associate

+

artist

artist

"as a founder turned investor, working at redalpine provides me with a unique opportunity to support visionaries who are pushing the frontiers of innovation in health and biotech."

led healthtech startup to successful acquisition

oxford fellow, healthcare expert

when not working with entrepreneurs, inna is a fellow at the university of oxford, developing novel phenotype algorithms to support businesses in delivering more cost-efficient clinical trials. prior to this, inna worked in consulting, covering health financing and market access. inna holds a phd in health economics from the university of oxford, an msc in health economics and policy from the london school of economics, and a ba(hons) in economics and law from the american university of paris.

prior to redalpine, inna co-founded mable, a genomics-powered telehealth clinic for migraine care in the u.s., backed by y combinator, illumina inc and initialized capital. having gone through the full start-up life cycle from inception, regulatory approval and launch to acquisition in 2023, Inna is now closely working with founders globally to develop g2m, reimbursement and growth strategies.

for a change of pace, inna enjoys travel, sports and art.

bottom of page